Search
AVONEX 30 µg, Poudre + solvant (Retiré du marché)
Details
| --- | Description |
|---|---|
| Pack | Boîte de 4 doses |
| Strength (Dosage) | |
| Laboratory | SOTHEMA |
| Ingredients | Interféron bêta 1 a |
| Therapeutic class | Immunomodulateur, interféron lors de sclérose en plaques |
| ATC code | L03AB07 |
| PPH | $960.60 |
| PPV | $981.80 |
| Refundable | Yes |
| Refund base | $981.80 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Avonex est indiqué pour le traitement de la sclérose en plaques évoluant par poussées, pour ralentir la progression de la maladie et diminuer la fréquence des poussées. Chez les patients ayant présenté un seul épisode de démyélinisation et dont le tomogramme par RMN est suspect, Avonex diminue le risque de poussées. Avonex n’a pas encore été étudié chez les patients atteints d’une forme progressive de sclérose en plaques. Les patients ne répondent pas tous au traitement par Avonex. Aucun critère clinique ne permet cependant de prédire la réponse au traitement d’un patient. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
REBIF 44 µg, Injectable
Immunomodulateur, interféron lors de sclérose en plaques
Interféron bêta 1 a
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem